Methohexital Sodium · METHOHEXITAL SODIUM 500 mg/500mg · Injection · Intramuscular; Intravenous; Rectal · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC 23155-0893-31 · 1 VIAL in 1 CARTON / 500 mg in 1 VIAL · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. A Class II recall hit this product in the past year (Onesource Specialty Pharma Limited).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | METHOHEXITAL SODIUM 500 mg/500mg | Jul 15, 2026 | Sep 2, 2026 |
| Onesource Specialty Pharma Limited | METHOHEXITAL SODIUM 500 mg/500mg | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Methohexital Sodium — NDC 23155-0893-31," retrieved September 3, 2026, https://drugdashboards.com/drug/23155089331.
Free to cite with attribution — see how the data is put together.